Spectrum-FDA OKs Generic Version of Cipro  CHICAGO (Reuters) - Spectrum Pharmaceuticals &lt;A HREF="http://www.investor.reuters.com/FullQuote.aspx?ticker=SPPI.O target=/stocks/quickinfo/fullquote"&gt;SPPI.O&lt;/A&gt; said  on Friday U.S. regulators have approved its generic version of  Bayer's &lt;A HREF="http://www.investor.reuters.com/FullQuote.aspx?ticker=BAYG.DE target=/stocks/quickinfo/fullquote"&gt;BAYG.DE&lt;/A&gt;  Cipro antibiotic, triggering a \$750,000  equity investment by one of its partners.